Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia
Authors
Keywords
-
Journal
npj Genomic Medicine
Volume 2, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-10
DOI
10.1038/s41525-017-0015-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations
- (2016) Venkateshwar Mutyam et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
- (2016) Chi B. Vu et al. JOURNAL OF MEDICINAL CHEMISTRY
- From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
- (2016) Gudio Veit et al. MOLECULAR BIOLOGY OF THE CELL
- Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
- (2016) Johanna F. Dekkers et al. Science Translational Medicine
- Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients
- (2015) M. D. Amaral JOURNAL OF INTERNAL MEDICINE
- Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization
- (2015) M J Gold et al. Mucosal Immunology
- Directed differentiation of cholangiocytes from human pluripotent stem cells
- (2015) Mina Ogawa et al. NATURE BIOTECHNOLOGY
- Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells
- (2015) Amy P Wong et al. Nature Protocols
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Testing gene therapy vectors in human primary nasal epithelial cultures
- (2015) Huibi Cao et al. Molecular Therapy-Methods & Clinical Development
- VX-809 and Related Corrector Compounds Exhibit Secondary Activity Stabilizing Active F508del-CFTR after Its Partial Rescue to the Cell Surface
- (2014) Paul D.W. Eckford et al. CHEMISTRY & BIOLOGY
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype
- (2014) J P Clancy et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Combined effects of VX-770 and VX-809 on several functional abnormalities of F508del-CFTR channels
- (2014) Z. Kopeikin et al. Journal of Cystic Fibrosis
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation
- (2014) Stan Pasyk et al. PROTEOMICS
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
- (2014) Michael P Boyle et al. Lancet Respiratory Medicine
- Efficient generation of lung and airway epithelial cells from human pluripotent stem cells
- (2013) Sarah X L Huang et al. NATURE BIOTECHNOLOGY
- A functional CFTR assay using primary cystic fibrosis intestinal organoids
- (2013) Johanna F Dekkers et al. NATURE MEDICINE
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner
- (2012) Paul D. W. Eckford et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ivacaftor potentiation of multiple CFTR channels with gating mutations
- (2012) Haihui Yu et al. Journal of Cystic Fibrosis
- Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein
- (2012) Amy P Wong et al. NATURE BIOTECHNOLOGY
- Functional Rescue of F508del-CFTR Using Small Molecule Correctors
- (2012) Steven Molinski et al. Frontiers in Pharmacology
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for direct CFTR inhibition by CFTRinh-172 based on Arg347mutagenesis
- (2008) Emanuela Caci et al. BIOCHEMICAL JOURNAL
- High-content Functional Screen to Identify Proteins that Correct F508del-CFTR Function
- (2008) Agata M. Trzcińska-Daneluti et al. MOLECULAR & CELLULAR PROTEOMICS
- Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules
- (2008) F RUSSEL et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now